Absci (ABSI) Operating Expenses (2020 - 2026)
Absci (ABSI) reported Operating Expenses of $31.1 million for Q1 2026, up 7.45% on a YoY basis from $28.9 million in Q1 2025, and down 1.99% sequentially from $31.7 million in Q4 2025.
Absci (ABSI) Operating Expenses (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Operating Expenses data on file, last reported at $31.1 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 7.45% year-over-year to $31.1 million; the trailing twelve-month figure through Mar 2026 stood at $125.3 million (up 6.22% YoY), and the FY2025 full-year result was $123.1 million, up 8.55% from the prior year.
- Operating Expenses eased to $31.1 million in Q1 2026, from $31.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $46.4 million in Q2 2023 to a low of $22.6 million in Q4 2022.
- A 5-year average of $29.5 million and a median of $29.9 million in 2022 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses soared 142.58% in 2022 and tumbled 39.62% in 2024, its largest moves.
- Tracing ABSI's Operating Expenses over 5 years: stood at $22.6 million in 2022, then rose by 10.72% to $25.1 million in 2023, then rose by 21.38% to $30.4 million in 2024, then advanced by 4.11% to $31.7 million in 2025, then slipped by 1.99% to $31.1 million in 2026.
- Business Quant data shows ABSI's Operating Expenses at $31.1 million in Q1 2026, $31.7 million in Q4 2025, and $30.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 31.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.06 Mn |
| Dec 31, 2025 | 31.69 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Jun 30, 2025 | 31.99 Mn |
| Mar 31, 2025 | 28.91 Mn |
| Dec 31, 2024 | 30.44 Mn |
| Sep 30, 2024 | 30.60 Mn |
| Jun 30, 2024 | 27.99 Mn |
| Mar 31, 2024 | 24.40 Mn |
| Dec 31, 2023 | 25.08 Mn |
| Sep 30, 2023 | 24.05 Mn |
| Jun 30, 2023 | 46.36 Mn |
| Mar 31, 2023 | 25.75 Mn |
| Dec 31, 2022 | 22.65 Mn |
| Sep 30, 2022 | 30.34 Mn |
| Jun 30, 2022 | 29.89 Mn |
| Mar 31, 2022 | 29.62 Mn |
| Dec 31, 2021 | 27.71 Mn |
| Sep 30, 2021 | 22.68 Mn |
| Jun 30, 2021 | 17.42 Mn |